{"id":592953,"date":"2022-03-24T20:08:01","date_gmt":"2022-03-24T20:08:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=592953"},"modified":"2022-03-24T20:08:01","modified_gmt":"2022-03-24T20:08:01","slug":"chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market_592953.html","title":{"rendered":"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1648029125.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market\" src=\"https:\/\/www.abnewswire.com\/uploads\/1648029125.jpeg\" alt=\"Chemotherapy Induced Anemia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Chemotherapy Induced Anemia Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Chemotherapy-Induced Anemia in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight has launched a new report on <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">&#8220;Chemotherapy Induced Anemia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&rdquo;.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>DelveInsight&rsquo;s <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">&ldquo;Chemotherapy Induced Anemia &ndash; Market Insights, Epidemiology, and Market Forecast-2030&Prime;<\/a> report deliver an in-depth understanding of the Chemotherapy Induced Anemia, historical and forecasted epidemiology as well as the Chemotherapy Induced Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Chemotherapy Induced Anemia Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to Langa et al (2015) the prevalence of anemia (hemoglobin [Hb] level<\/li>\n<li>According to study by Cannavale et al (2019),&nbsp; of 699 chemotherapy-treated patients with NHL diagnosed between 2010 and 2012, 36.9% and 11.6% developed moderate (hemoglobin &lt; 10 g\/dL) and severe (hemoglobin &lt; 8 g\/dL) CIA during chemotherapy.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>Chemotherapy Induced Anemia market report covers a descriptive overview and comprehensive insight of the Chemotherapy Induced Anemia Epidemiology and Chemotherapy Induced Anemia&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Chemotherapy Induced Anemia market report provides insights on the current and emerging therapies.<\/li>\n<li>Chemotherapy Induced Anemia market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Chemotherapy Induced Anemia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chemotherapy Induced Anemia market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Got queries? <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chemotherapy-induced-anemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Click here to know more about the Chemotherapy Induced Anemia Market Landscape.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chemotherapy Induced Anemia Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Anemia is the most common and persistent hematological abnormality in oncology patients. Chemotherapy-induced anemia (CIA) is a consequence of the malignant invasion of normal tissue leading to blood loss, bone marrow infiltration with disruption of erythropoiesis, and functional iron deficiency as a consequence of inflammation.<\/p>\n<p style=\"text-align: justify;\">Fatigue is the most common symptom of CIA, although vertigo, loss of appetite, poor concentration, and dyspnea are also frequently reported. Grade of anemia in combination with a type of cancer and baseline cardiopulmonary function contribute to symptom severity.<\/p>\n<p style=\"text-align: justify;\"><strong>Chemotherapy Induced Anemia Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chemotherapy-induced-anemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Chemotherapy Induced Anemia market<\/a> are anticipated to change in the coming years owing to the expected launch of emerging therapies such as FibroGen, and others during the forecasted period 2018-2030.<\/p>\n<p style=\"text-align: justify;\"><strong>Learn more by requesting for sample <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chemotherapy-induced-anemia-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">@ Chemotherapy Induced Anemia Market Landscape&nbsp;<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chemotherapy Induced Anemia Pipeline Therapies and Key Companies&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Roxadustat: FibroGen<\/li>\n<li>And Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Chemotherapy Induced Anemia Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Chemotherapy Induced Anemia Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Chemotherapy Induced Anemia Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Chemotherapy Induced Anemia Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Chemotherapy-Induced Anemia&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Chemotherapy Induced Anemia Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Chemotherapy Induced Anemia Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Chemotherapy Induced Anemia Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Chemotherapy Induced Anemia Market Analysis (2018&ndash;2030)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Chemotherapy Induced Anemia Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chemotherapy Induced Anemia Market DelveInsight\u2019s \u2018Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast \u2013 2032\u2019 report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Chemotherapy-Induced Anemia in the United States, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/chemotherapy-induced-anemia-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market_592953.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,413,404],"tags":[],"class_list":["post-592953","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Services","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/592953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=592953"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/592953\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=592953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=592953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=592953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}